PMAD Screening in Clinical Practice: A Complete Reference for Perinatal Providers

Quick Reference

| Tool | Validated for | Positive screen threshold | Action threshold | Timing | |---|---|---|---|---| | EPDS (10-item) | Depression, anxiety | ≥10 | ≥13 (probable major depression) | Prenatal: 1st + 3rd trimester. Postpartum: 1, 2, 4, 6 months | | PHQ-9 | Depression | ≥10 (moderate) | ≥15 (moderate-severe) | Flexible; useful when transitioning from EPDS | | GAD-7 | Generalized anxiety | ≥10 (moderate) | ≥15 (severe) | In conjunction with EPDS or PHQ-9 | | PHQ-4 | Depression + anxiety combined screen | ≥3 on either subscale | Positive screen prompts full tool | Ultra-brief; useful in high-volume settings |

ICD-10 codes for PMAD documentation:

| Diagnosis | ICD-10 code | |---|---| | Postpartum depression | F53.0 | | Postpartum psychosis | F53.1 | | Major depressive disorder, moderate, peripartum onset | F32.1 with Z3A or Z3B specifier | | Generalized anxiety disorder | F41.1 | | OCD | F42.2 | | Perinatal anxiety (not otherwise specified) | F41.8 | | Fear of childbirth (tokophobia) | F40.298 |

---

Why Routine Screening Is the Standard, Not Best Practice

Approximately 1 in 5 postpartum patients develops a clinically significant perinatal mood and anxiety disorder (PMAD). In a typical obstetric practice seeing 200 postpartum patients annually, that translates to 30 to 40 new cases per year. The majority will not self-report.

The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women (Grade B recommendation, 2016). ACOG Practice Bulletin 343 (2023) recommends screening at least once in the prenatal period and at the postpartum visit, using a validated instrument. The American Academy of Pediatrics recommends that pediatricians screen mothers at the 1-, 2-, 4-, and 6-month well-child visits (AAP policy statement, Earls et al., 2019 reaffirmed 2021).

These are not aspirational guidelines. They represent the current standard of care. When a postpartum patient develops severe depression, attempts self-harm, or loses her pregnancy, the chart will be reviewed. Documentation of screening -- or its absence -- is clinically and medicolegally relevant.

---

The Edinburgh Postnatal Depression Scale (EPDS)

The EPDS is the most widely validated PMAD screening tool in the world, with over three decades of psychometric data across diverse populations. It has 10 items rated 0 to 3, with a maximum score of 30.

Scoring and clinical thresholds

Score 0 to 9: Low likelihood of major depression. Continue routine monitoring.

Score 10 to 12: Elevated risk. Clinical judgment required. Factors to consider: social support, prior psychiatric history, obstetric complications, sleep deprivation severity. Rescreening in 2 to 4 weeks is appropriate.

Score 13 and above: Probable major depressive episode. Warm referral to perinatal mental health specialist indicated. Same-day safety assessment if score on item 10 (suicidal ideation) is 1 or higher.

Item 10 specifically: "The thought of harming myself has occurred to me." Any score above 0 on this item requires direct clinical assessment regardless of total score. A total score of 8 with item 10 scored at 2 is a more urgent clinical situation than a total score of 14 with item 10 at 0.

What the EPDS measures (and what it does not)

The EPDS was designed to screen for postnatal depression. It also performs reasonably well as an anxiety screen: questions 3, 4, and 5 load on an anxiety factor and a subset cutoff of 6 or above on items 3 through 10 has been proposed as an anxiety screen, though this use has less validation than the full-scale depression application.

The EPDS does not screen effectively for postpartum OCD, PTSD, or bipolar disorder. A patient scoring 7 on the EPDS is not necessarily low-risk -- she may have intrusive thoughts, a birth trauma response, or a hypomanic episode that the instrument was not built to capture. Clinical interview remains essential when the presentation suggests disorders outside the EPDS's validated range.

Timing recommendations

ACOG Practice Bulletin 343 recommends screening at least once prenatally and once postpartum. PSI and MCPAP (Massachusetts Child Psychiatry Access Program) recommend more comprehensive timing:

• Prenatal: First trimester (baseline) and third trimester (30 to 34 weeks)
• Postpartum: 1 month, 2 months, 4 months, 6 months

For patients with a prior PMAD history, bipolar history, or significant prenatal depression score, additional prenatal screening is appropriate.

---

PHQ-9 in Perinatal Settings

The PHQ-9 is widely used in primary care and integrates naturally into practices already using it for general depression screening. It is validated for perinatal populations, though the EPDS generally demonstrates superior sensitivity and specificity in peripartum women.

Perinatal-specific considerations

Item 3 ("Trouble falling or staying asleep, or sleeping too much") conflates sleep disruption from infant care with neurovegetative depression symptoms. This commonly inflates scores in the early postpartum period. Clinical interpretation requires accounting for sleep that is interrupted by a newborn versus sleep that is non-restorative due to anhedonia and psychomotor symptoms.

PHQ-9 scoring thresholds in perinatal practice:

| Score | Interpretation | Clinical action | |---|---|---| | 1 to 4 | Minimal | Monitor | | 5 to 9 | Mild | Watchful waiting, psychoeducation, rescreening in 4 weeks | | 10 to 14 | Moderate | Referral for therapy; consider pharmacology consult | | 15 to 19 | Moderately severe | Referral + pharmacology discussion | | 20 to 27 | Severe | Urgent referral; consider higher level of care |

---

GAD-7 for Perinatal Anxiety

Anxiety disorders are more prevalent in the perinatal period than depression, though they receive less clinical attention. Approximately 15 to 20 percent of pregnant and postpartum women develop clinically significant anxiety (Fawcett et al., JAMA Psychiatry, 2019). The GAD-7 screens for generalized anxiety but has been used in perinatal settings as a broad anxiety indicator.

Cutoff scores:

• 5 to 9: Mild anxiety. Psychoeducation and lifestyle counseling appropriate.
• 10 to 14: Moderate anxiety. Referral to perinatal mental health recommended.
• 15 and above: Severe anxiety. Priority referral.

The GAD-7 does not distinguish between GAD, panic disorder, health anxiety, and the specific anxiety profile of postpartum OCD (which presents as intrusive, ego-dystonic thoughts with compulsive behaviors rather than diffuse worry). Clinicians who identify high anxiety scores should follow up with targeted questions about intrusive thoughts, checking behaviors, and fear of harming the infant.

---

Implementing Screening in Practice: Workflow Considerations

OB/Midwifery settings

The most efficient PMAD screening workflow embeds the tool into existing prenatal intake paperwork and postpartum visit charting. Paper-based or EHR-embedded administration takes 2 to 3 minutes.

Recommended workflow for a positive screen (EPDS 10 or above):

1. Nurse or MA flags the result before the provider enters the room.
2. Provider opens the visit with direct acknowledgment: "Your screening score was elevated. I want to ask you a few more questions about how you've been feeling."
3. Assess severity, safety (item 10), support system, and functional impairment.
4. Score 10 to 12 with no safety concerns and good support: rescreening at next visit plus watchful waiting. Brief psychoeducation is appropriate.
5. Score 13 and above, or any item 10 score above 0: warm referral to perinatal mental health specialist.
6. Document the score, clinical impression, and disposition plan in the chart.

Pediatric settings

AAP guidelines position well-child visits as a touchpoint for maternal mental health screening because pediatricians often see the mother more frequently in the first year than her own providers. The pediatric visit is a non-stigmatizing context.

Recommended workflow:

1. Administer EPDS at the 1-, 2-, 4-, and 6-month well visits via paper or patient portal.
2. Medical assistant reviews score and flags to provider.
3. A positive screen in a pediatric setting should result in: (a) direct conversation with the mother; (b) provision of referral resources; (c) documentation in the chart.
4. Pediatricians should have a prepared referral pathway. The most common barrier to acting on a positive maternal screen in a pediatric setting is not knowing where to send the patient. Establishing a relationship with a perinatal mental health provider resolves this.

---

Special Populations and Screening Modifications

Patients with prior psychiatric history

Patients with a prior major depressive episode have a 25 to 50 percent recurrence risk in the peripartum period (Howard et al., Lancet, 2014). Patients with bipolar I or II disorder face 50 percent or greater risk of peripartum mood episode. For these patients, screen more frequently (monthly prenatal, every 2 weeks postpartum for the first 3 months), use clinical interview to supplement tools, and maintain close coordination with the prescribing provider.

NICU families

Parents of NICU-admitted infants have markedly elevated PMAD rates: approximately 30 to 40 percent of NICU mothers screen positive for depression, and rates of acute stress disorder and PTSD significantly exceed the general postpartum population (Hynan et al., Journal of Perinatology, 2015). The standard well-visit schedule does not capture NICU families during the period of maximum vulnerability. NICU social workers and nurses should administer validated screening to mothers and fathers beginning within the first 2 weeks of NICU admission.

Fertility patients

Patients completing IVF cycles have significantly elevated rates of perinatal depression and anxiety compared with spontaneous conception (Chen et al., Human Reproduction, 2021). This population often has pre-existing anxiety related to infertility treatments, pregnancy loss history, and high-stakes monitoring. Screening should begin at fertility treatment initiation and continue through the first trimester of pregnancy.

---

Documentation Standards

Documenting PMAD screening protects both the patient and the practice. The chart should include:

• The tool used
• The numeric score
• Date administered
• Clinical interpretation and disposition
• Item 10 status (suicidal ideation) explicitly noted if score is above 0

Undocumented verbal screening carries no legal weight and cannot support continuity of care. If you screened and didn't chart it, it did not happen in the medical record.

---

When a Screen Is Positive: The Referral Decision

A positive screen is the beginning of a clinical decision, not the end of a workflow. The disposition depends on:

• Severity of symptoms
• Safety risk
• Functional impairment
• Support system
• Patient's preference and readiness
• Access to care

Mild elevation (EPDS 10 to 12) without safety concerns and with functional preservation is appropriate for watchful waiting with follow-up. Moderate to severe elevation, any safety concern, prior psychiatric history, or functional impairment warrants prompt referral to a perinatal-specialized therapist.

Most general therapists do not specialize in perinatal mental health. The PMH-C (Perinatal Mental Health Certification from Postpartum Support International) is the credentialing standard for this subspecialization. Referrals to PMH-C certified clinicians result in better-matched care for this population.

For a detailed referral workflow including warm handoff protocols, patient communication scripts, and what to expect after the referral, see our article on building a PMAD referral pathway in an OB practice.

---